Path to the Clinic: Assessment of iPSC-Based Cell Therapies In Vivo in a Nonhuman Primate Model
Induced pluripotent stem cell (iPSC)-based cell therapies have great potential for regenerative medicine but are also potentially associated with tumorigenic risks. Current rodent models are not optimal predictors of efficiency and safety for clinical application. Therefore, we developed a clinicall...
Main Authors: | So Gun Hong, Thomas Winkler, Chuanfeng Wu, Vicky Guo, Stefania Pittaluga, Alina Nicolae, Robert E. Donahue, Mark E. Metzger, Sandra D. Price, Naoya Uchida, Sergei A. Kuznetsov, Tina Kilts, Li Li, Pamela G. Robey, Cynthia E. Dunbar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-05-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124714003064 |
Similar Items
-
Nonhuman primate models for SARS.
by: Bart L Haagmans, et al.
Published: (2006-05-01) -
MHC matching improves engraftment of iPSC-derived neurons in non-human primates
by: Asuka Morizane, et al.
Published: (2017-08-01) -
Viruses from Nonhuman Primates
by: Regis A. Vilchez
Published: (2006-11-01) -
Nonhuman gamblers: lessons from rodents, primates, and robots
by: Fabio ePaglieri, et al.
Published: (2014-02-01) -
Exposure to Nonhuman Primates in Rural Cameroon
by: Nathan D. Wolfe, et al.
Published: (2004-12-01)